A polymorphic variant in the MHC2TA gene is not associated with systemic lupus erythematosus

Tissue Antigens

Volumn 70, Issue 5, 2007, Pages 412-414

  Linga Reddy, M V Prasad ^a   Gunnarsson, I ^b   Svenungsson, E ^b   Sturfelt, G ^c   Jonsen A ^c   Truedsson, L ^c   Nordmark, G ^a   Ronnblom L ^a   Alarcon Riquelme M E ^a,d  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Class II transactivator; Major histocompatibility complex class II transactivator; Systemic lupus erythematosus

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2 TRANSACTIVATOR; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CASE CONTROL STUDY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SWEDEN; SYSTEMIC LUPUS ERYTHEMATOSUS;

ALLELES; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MULTIPLE SCLEROSIS; MYOCARDIAL INFARCTION; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SWEDEN; TRANS-ACTIVATORS;

EID: 35148867770     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2007.00920.x     Document Type: Article

References (12)

1. Haines JL, Garcia ME, Barcellos L, Oksenberg JR, Hauser SL, Pericak, VM. Chromosome 16p13-cen and the MHC in multiple sclerosis. Am Soc Hum Genet 1999 : 65 (Suppl A252 (Abstr. 1406).
2. Waldburger JM, Masternak K, Muhlethaler-Mottet A et al. Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression. Immunol Rev 2000 : 178 : 148 65.
3. Haines JL, Ter-Minassian M, Bazyk A et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat Genet 1996 : 13 : 469 71.
4. Muhlethaler-Mottet A, Otten LA, Steimle V, Mach B. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J 1997 : 16 : 2851 60.
5. Lennon AM, Ottone C, Rigaud G et al. Isolation of a B-cell-specific promoter for the human class II transactivator. Immunogenetics 1997 : 45 : 266 73.
6. Mach B, Steimle V, Martinez-Soria E, Reith W. Regulation of MHC class II genes: lessons from a disease. Ann Rev Immunol 1996 : 14 : 301 31.
7. Silacci P, Mottet A, Steimle V, Reith W, Mach B. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J Exp Med 1994 : 180 : 1329 36.
8. Sartoris S, Tosi G, De Lerma Barbaro A, Cestari T, Accolla RS. Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells. Eur J Immunol 1996 : 26 : 2456 60.
9. Swanberg M, Lidman O, Padyukov L et al. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 2005 : 37 : 486 94.
10. Alarcon-Segovia D. Shared autoimmunity: the time has come. Curr Rheumatol Rep 2004 : 6 : 171 4.
11. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982 : 25 : 1271 7.
12. Helgason A, Yngvadottir B, Hrafnkelsson B, Gulcher J, Stefansson K. An Icelandic example of the impact of population structure on association studies. Nat Genet 2005 : 37 : 90 5.